The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 210K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cella, M.
Right arrow Articles by Lanzavecchia, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cella, M.
Right arrow Articles by Lanzavecchia, A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1999/3/821/ $5.00
The Journal of Experimental Medicine, Volume 189, Number 5, March 1, 1999 821-829

Articles

Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA

Marina Cella*, Mariolina Salio*, Yoichi Sakakibara*, Hanno Langen{ddagger}, Ilkka Julkunen§, and Antonio Lanzavecchia*

From the * Basel Institute for Immunology, CH-4005 Basel, Switzerland; {ddagger} Hoffmann-La Roche AG, CH-4002 Basel, Switzerland; and the § National Public Health Institute, FIN-00300, Helsinki, Finland

The initiation of an immune response is critically dependent on the activation of dendritic cells (DCs). This process is triggered by surface receptors specific for inflammatory cytokines or for conserved patterns characteristic of infectious agents. Here we show that human DCs are activated by influenza virus infection and by double-stranded (ds)RNA. This activation results not only in increased antigen presentation and T cell stimulatory capacity, but also in resistance to the cytopathic effect of the virus, mediated by the production of type I interferon, and upregulation of MxA. Because dsRNA stimulates both maturation and resistance, DCs can serve as altruistic antigen-presenting cells capable of sustaining viral antigen production while acquiring the capacity to trigger naive T cells and drive polarized T helper cell type 1 responses.

Key Words: dendritic cell maturation and activation • influenza virus • double-stranded RNA • type I interferon • MxA

Address correspondence to Marina Cella or Antonio Lanzavecchia, Basel Institute for Immunology, Grenzacherstrasse 487, CH 4005 Basel, Switzerland. Phone: 41-61-6051326; Fax: 41-61-6051222; E-mail: cella{at}bii.ch or lanzavecchia{at}bii.ch

M. Salio holds an EC fellowship (EUNIDI). The Basel Institute for Immunology was founded and is supported by Hoffmann-La Roche, Basel, Switzerland.

Abbreviations used: CD40L, CD40 ligand; DC, dendritic cell; ds, double-stranded; MOI, multiplicity of infection.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS